Why the study?
The authors aimed to investigate the incidence of new acute myocardial infarction in patients with COVID-19 who had a prior myocardial infarction.
Does COVID-19 increase the risk of new myocardial infarction in patients with a history of old myocardial infarction?
Does COVID-19 increase the risk of new myocardial infarction in patients with a history of old myocardial infarction?
COVID-19 infection is associated with a high rate of recurrent AMI in patients with a history of prior MI, while COVID-19 severity independently predicts mortality.
Answers are grounded in this paper and cite their sources.
May suggest elevated recurrent AMI risk in COVID-19 patients with prior MI; hypothesis-generating and leaves causal confirmation open.
Background: We aimed to investigate the incidence of new acute myocardial infarction (AMI), in patients with Coronavirus disease (COVID-19) who had old MI. We hypothesized that COVID-19 increases the rate of repeated AMI in this population regardless of age and gender. Methods: A retrospective analysis was conducted for adult patients admitted with COVID-19 and developed thromboembolic event (TEE) in 2020. Patients were categorized based on the history of old MI, new MI, age, and gender. Results: Among 16,903 patients with COVID-19 who were admitted, 210 (1.2%) developed TEE (89% were males, 55% were <55 years old, and 80.5% had an old MI). COVID-19 was severe in 32% of cases. AMI occurred in 160 patients (42.5% STEMI and 57.5% NSTEMI). In patients with prior MI, 92.5% developed another AMI. NSTEMI was higher in patients with severe COVID-19 than STEMI (33% vs 21%). Patients with severe COVID-19 had higher mortality (39.4% vs 5.6%), fewer rates of prior MI (74% vs 83%), hypertension (40% vs 60%), and STEMI (31.8% vs 46.5%) than mild COVID-19 patients. On multivariable analysis, COVID-19 severity was an independent predictor of mortality (OR10; 95%CI 1.62-67.19) after adjustment for age, gender, diabetes mellitus, C-reactive protein, serum Ferritin, Procalcitonin, and Fibrinogen values, and prior or new MI. Conclusions: Patients with old MI could develop a new AMI in 80% of COVID-19. However, the mortality was higher in patients without a history of MI due to the severity of COVID-19. Attention should be given to patients who possess thrombotic risk factors in pandemics.
No takes yet. Share an insight, caveat, or question.
El‐Menyar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: